Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination

Adher D. Al Sayed; Mahmoud A. Elshenawy; Asma Tulbah; Taher Al-Tweigeri; Hazem Ghebeh

doi:10.12659/AJCR.918770

Back

$Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination$

Journal article

Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination

Adher D. Al Sayed, Mahmoud A. Elshenawy, Asma Tulbah, Taher Al-Tweigeri and Hazem Ghebeh

The American journal of case reports, Vol.20, pp.1630-1635

06/11/2019

DOI: https://doi.org/10.12659/AJCR.918770

PMCID: PMC6858626

PMID: 31690713

Abstract

Antigens, CD274

Paclitaxel

Triple Negative Breast Neoplasms

Patient: Female, 49 Final Diagnosis: Metastatic metaplastic breast cancer Symptoms: Progressive right breast mass Medication: 5-fluorouracil • Cytoxan • Epirubicin (FEC 100) • Docetaxel • Capecitabine Clinical Procedure: Mastectomy • Radiation Therapy Specialty: Oncology

Metrics

1 Record Views

See more details

Details

Title: Complete Response of Chemo-Refractory Metastatic Metaplastic Breast Cancer to Paclitaxel-Immunotherapy Combination
Creators - without role: Adher D. Al Sayed - King Faisal Specialist Hospital & Research Centre
Mahmoud A. Elshenawy - King Faisal Specialist Hospital & Research Centre
Asma Tulbah - King Faisal Specialist Hospital & Research Centre
Taher Al-Tweigeri - King Faisal Specialist Hospital & Research Centre
Hazem Ghebeh - King Faisal Specialist Hospital & Research Centre
Publication Details: The American journal of case reports, Vol.20, pp.1630-1635
Publisher: International Scientific Literature, Inc
Identifiers: 9913670108331
Academic Unit: King Faisal University; Alfaisal University
Language: English
Resource Type: Journal article